2004
DOI: 10.1128/mcb.24.17.7435-7443.2004
|View full text |Cite
|
Sign up to set email alerts
|

Disruption of the SH2-B Gene Causes Age-Dependent Insulin Resistance and Glucose Intolerance

Abstract: Insulin regulates glucose homeostasis by binding and activating the insulin receptor, and defects in insulin responses (insulin resistance) induce type 2 diabetes. SH2-B, an Src homology 2 (SH2) and pleckstrin homology domain-containing adaptor protein, binds via its SH2 domain to insulin receptor in response to insulin; however, its physiological role remains unclear. Here we show that SH2-B was expressed in the liver, skeletal muscle, and fat. Systemic deletion of SH2-B impaired insulin receptor activation a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
116
0

Year Published

2006
2006
2018
2018

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 117 publications
(123 citation statements)
references
References 53 publications
7
116
0
Order By: Relevance
“…SH2B1 is a widely-expressed cytoplasmic protein that simultaneously binds, via its Src homology 2 (SH2) domain, to both Janus kinase 2 (JAK2) and insulin receptor substrate 2 (IRS2), thereby promoting the leptin-induced activation of the phosphoinositide 3-kinase signaling pathway in cultured cells (25,26). SH2B1-deficient mice develop insulin resistance and type 2 diabetes mellitus (27) as well as severe leptin resistance, hyperphagia and obesity (28). SH2B1 is thus a key cytoplasmic signaling molecule that acts as a positive regulator of leptin and insulin signal transduction in mice.…”
Section: Discussionmentioning
confidence: 99%
“…SH2B1 is a widely-expressed cytoplasmic protein that simultaneously binds, via its Src homology 2 (SH2) domain, to both Janus kinase 2 (JAK2) and insulin receptor substrate 2 (IRS2), thereby promoting the leptin-induced activation of the phosphoinositide 3-kinase signaling pathway in cultured cells (25,26). SH2B1-deficient mice develop insulin resistance and type 2 diabetes mellitus (27) as well as severe leptin resistance, hyperphagia and obesity (28). SH2B1 is thus a key cytoplasmic signaling molecule that acts as a positive regulator of leptin and insulin signal transduction in mice.…”
Section: Discussionmentioning
confidence: 99%
“…4). 28) This gene has recently been reported to be expressed at accelerated leaves in monocytes and lymphocytes in NIDDM patients after onset. 29) This report supports our hypothesis that the expression of NIDDMrelated genes is altered in blood cells before onset.…”
Section: Fig 4 Schematic Representation Of Niddm Related Signals Inmentioning
confidence: 99%
“…SH2B1 -/-mice exhibit a variety of phenotypes (Duan et al, 2004b;Ohtsuka et al, 2002;Ren et al, 2005), including obesity and insulin-resistance, consistent with SH2B1 serving as an adapter or scaffold protein for leptin and insulin (Duan et al, 2004b;Ren et al, 2005). SH2B1 was recently identified as a candidate human obesity gene in genetic studies of patients exhibiting severe early-onset childhood obesity, developmental delay and insulin resistance (Bochukova et al, 2010;Renstrom et al, 2009;Walters et al, 2010).…”
Section: Introductionmentioning
confidence: 99%